Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8233 ARTÍCULOS , VIENDO DEL 3241 AL 3255

Exploring the Potential of Neuroproteomics in Alzheimer's Disease

Uddin MS, Kabir MT, Jakaria M, Sobarzo-Sánchez E, Barreto GE, Perveen A, Hafeez A, Bin-Jumah MN, Abdel-Daim MM, Ashraf GM.

Curr Top Med Chem. 2020;20(25):2263-2278. doi: 10.2174/1568026620666200603112030.

Biosensing: The best alternative for conventional methods in detection of Alzheimer's disease biomarkers

Mobed A, Hasanzadeh M.

Int J Biol Macromol. 2020 Oct 15;161:59-71. doi: 10.1016/j.ijbiomac.2020.05.257. Epub 2020 Jun 3.

Alzheimer's Disease in Down Syndrome: Progress in the Design and Conduct of Drug Prevention Trials

Rafii MS.

CNS Drugs. 2020 Aug;34(8):785-794. doi: 10.1007/s40263-020-00740-6.

Safety, Tolerability, and Pharmacokinetics of Crenezumab in Patients with Mild-to-Moderate Alzheimer's Disease Treated with Escalating Doses for up to 133 Weeks

Guthrie H, Honig LS, Lin H, Sink KM, Blondeau K, Quartino A, Dolton M, Carrasco-Triguero M, Lian Q, Bittner T, Clayton D, Smith J, Ostrowitzki S.

J Alzheimers Dis. 2020;76(3):967-979. doi: 10.3233/JAD-200134.

Anti-human TREM2 induces microglia proliferation and reduces pathology in an Alzheimer's disease model

Wang S, Mustafa M, Yuede CM, Salazar SV, Kong P, Long H, Ward M, Siddiqui O, Paul R, Gilfillan S, Ibrahim A, Rhinn H, Tassi I, Rosenthal A, Schwabe T, Colonna M.

J Exp Med. 2020 Sep 7;217(9):e20200785. doi: 10.1084/jem.20200785.

Biosensors for detection of Tau protein as an Alzheimer's disease marker

Ameri M, Shabaninejad Z, Movahedpour A, Sahebkar A, Mohammadi S, Hosseindoost S, Ebrahimi MS, Savardashtaki A, Karimipour M, Mirzaei H.

Int J Biol Macromol. 2020 Nov 1;162:1100-1108. doi: 10.1016/j.ijbiomac.2020.06.239. Epub 2020 Jun 27.

Leveraging preclinical models for the development of Alzheimer disease therapeutics

Scearce-Levie K, Sanchez PE, Lewcock JW.

Nat Rev Drug Discov. 2020 Jul;19(7):447-462. doi: 10.1038/s41573-020-0065-9. Epub 2020 Apr 8.

Challenges in Alzheimer's Disease Diagnostic Work-Up: Amyloid Biomarker Incongruences

Lombardi G, Pupi A, Bessi V, Polito C, Padiglioni S, Ferrari C, Lucidi G, Berti V, De Cristofaro MT, Piaceri I, Bagnoli S, Nacmias B, Sorbi S.

J Alzheimers Dis. 2020;77(1):203-217. doi: 10.3233/JAD-200119.

Correlation of Alzheimer Disease Neuropathologic Staging with Amyloid and Tau Scintigraphic Imaging Biomarkers

Koychev I, Hofer M, Friedman N.

J Nucl Med. 2020 Oct;61(10):1413-1418. doi: 10.2967/jnumed.119.230458. Epub 2020 Aug 6.

Associations of Green Tea Consumption and Cerebrospinal Fluid Biomarkers of Alzheimer's Disease Pathology in Cognitively Intact Older Adults: The CABLE Study

Ma YH, Wu JH, Xu W, Shen XN, Wang HF, Hou XH, Cao XP, Bi YL, Dong Q, Feng L, Tan L, Yu JT.

J Alzheimers Dis. 2020;77(1):411-421. doi: 10.3233/JAD-200410.

Cerebrolysin in the therapy of mild cognitive impairment and dementia due to Alzheimer's disease: 30 years of clinical use

Gavrilova SI, Alvarez A.

Med Res Rev. 2021 Sep;41(5):2775-2803. doi: 10.1002/med.21722. Epub 2020 Aug 17.

Revisiting the Amyloid Cascade Hypothesis: From Anti-Aβ Therapeutics to Auspicious New Ways for Alzheimer's Disease

Uddin MS, Kabir MT, Rahman MS, Behl T, Jeandet P, Ashraf GM, Najda A, Bin-Jumah MN, El-Seedi HR, Abdel-Daim MM.

Int J Mol Sci. 2020 Aug 14;21(16):5858. doi: 10.3390/ijms21165858.

Surface plasmon resonance biosensors for detection of Alzheimer's biomarkers; an effective step in early and accurate diagnosis

Rezabakhsh A, Rahbarghazi R, Fathi F.

Biosens Bioelectron. 2020 Nov 1;167:112511. doi: 10.1016/j.bios.2020.112511. Epub 2020 Aug 17.

PTI-125 Reduces Biomarkers of Alzheimer's Disease in Patients

Wang HY, Pei Z, Lee KC, Lopez-Brignoni E, Nikolov B, Crowley CA, Marsman MR, Barbier R, Friedmann N, Burns LH.

J Prev Alzheimers Dis. 2020;7(4):256-264. doi: 10.14283/jpad.2020.6.

A Framework for Developing Pharmacotherapy for Agitation in Alzheimer's Disease: Recommendations of the ISCTM* Working Group

O'Gorman C, Khoury R, Anderson A, Carter M, DiCesare F, Dubé S, Ereshefsky L, Grossberg G, Hefting N, Khan S, Lind S, Moebius H, Shiovitz T, Rosenberg P.

J Prev Alzheimers Dis. 2020;7(4):274-282. doi: 10.14283/jpad.2020.37.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias